FDA Guidance titled “Further Testing of Donations that are Reactive on a Licensed Donor Screening Test for Antibodies to Hepatitis C Virus; Guidance for Industry” was released on October 2, 2019 and recommends that CTS modify our current HCV reflex testing algorithm to support these best practices. The new algorithm will take effect on April 20, 2020.
Check out the Communication page for the complete details by clicking the link: Communications
As a friendly reminder, airlines often change their routine flights and cargo hours for hol...
Currently, there are limited supplies of the reagents used for HIV-1 Western Blot and HIV-2 EIA test...
CTS originally communicated that Tampa will convert from the current Grifols Ultrio Plus NAT triplex...
The CTS Medical Advisory Board recently agreed upon a revision to our standard testing algorithm thi...
On December 28, 2021, the FDA updated the emergency use authorization (EUA) for COVID-19 conva...
CTS will be transitioning to a new sFTP server for clients who send test request and/or receive...